Covestor LTD Castle Biosciences Inc Transaction History
Covestor LTD
- $150 Million
- Q1 2025
A detailed history of Covestor LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Covestor LTD holds 1,219 shares of CSTL stock, worth $22,575. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,219
Previous 936
30.24%
Holding current value
$22,575
Previous $25,000
4.0%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CSTL
# of Institutions
192Shares Held
26.6MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$56.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$37.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$27.2 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$23.4 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$22.2 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $487M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...